These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

684 related items for PubMed ID: 16735669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor.
    Gross NJ, Giembycz MA, Rennard SI.
    COPD; 2010 Apr; 7(2):141-53. PubMed ID: 20397815
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease.
    Pinner NA, Hamilton LA, Hughes A.
    Clin Ther; 2012 Jan; 34(1):56-66. PubMed ID: 22284994
    [Abstract] [Full Text] [Related]

  • 9. Roflumilast for the treatment of chronic obstructive pulmonary disease.
    Antoniu SA.
    Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD].
    Tatlicioğlu T.
    Tuberk Toraks; 2008 May; 56(4):472-84. PubMed ID: 19123088
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
    Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, Beume R.
    J Pharmacol Exp Ther; 2001 Apr; 297(1):280-90. PubMed ID: 11259555
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis.
    Schmidt BM, Kusma M, Feuring M, Timmer WE, Neuhäuser M, Bethke T, Stuck BA, Hörmann K, Wehling M.
    J Allergy Clin Immunol; 2001 Oct; 108(4):530-6. PubMed ID: 11590377
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Roflumilast for the treatment of chronic obstructive pulmonary disease.
    Rabe KF.
    Expert Rev Respir Med; 2010 Oct; 4(5):543-55. PubMed ID: 20649375
    [Abstract] [Full Text] [Related]

  • 19. Roflumilast: a novel treatment for chronic obstructive pulmonary disease.
    Reid DJ, Pham NT.
    Ann Pharmacother; 2012 Apr; 46(4):521-9. PubMed ID: 22433610
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.